Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
|
Expensive Underperformer
293.4500
-2.65
(
-0.89
%)
NSE
Mar 16, 2026
15:31 PM
New 52W Low in past week
Volume:
604.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
20 May 2022
293.45
-0.89%
SUVEN PHARMACEUTICALS LIMITED
Accumulate:
Cohance Lifesciences Ltd.
by
Geojit BNP Paribas
Target: 602
Recommendation
Target
Geojit BNP Paribas
Cohance Lifesciences has lost
-70.22%
in the last 6 Months
More from Cohance Lifesciences Ltd.
Recommended
IPO market remains active despite weak retail demand and a volatile market
|
16 Mar 2026, 05:41PM
Market closes higher on gains in banking, auto, and cement stocks
Trendlyne Marketwatch |
16 Mar 2026, 04:14PM
Five Interesting Stocks Today - March 13, 2026
The Baseline |
13 Mar 2026